Skip to content

Sirecust 420 Patient Dialog Monitor

by Siemens Medical Solutions USA, Inc.

510(k) K851400

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 5 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK851400 Date26 Jun 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 5 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXJ
Device Class
Class II
Regulation
21 CFR Part 870.2450
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Sirecust 420 Patient Dialog Monitor is a Display, Cathode-Ray Tube, Medical device designed for patient communication and monitoring in clinical settings. It facilitates real-time interaction between healthcare providers and patients, enabling dialogue and feedback during medical procedures, particularly in cardiovascular care. The device integrates visual and auditory cues to enhance patient engagement and support procedural workflows.

This monitor is supplied as a reusable medical device, intended for use in hospital or clinical environments where patient communication is critical. It operates under regulatory oversight as a Class II device under FDA regulation 870.2450, with a 510(k) clearance (K851400) granted in 1985. The device is not classified as MRI-safe or MRI-conditional, and no specific sterility requirements are noted in the regulatory data. Storage and handling follow standard medical device protocols for reusable equipment.

Other devices from Siemens Medical Solutions USA, Inc.

See all devices from Siemens Medical Solutions USA, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Sirecust 420 Patient Dialog Monitor used for?

    The Sirecust 420 Patient Dialog Monitor is designed to facilitate real-time interaction between healthcare providers and patients during medical procedures, particularly in cardiovascular care. It integrates visual and auditory cues to improve patient engagement and support procedural workflows by enabling dialogue and feedback.

  • Is the Sirecust 420 Patient Dialog Monitor reusable or single-use?

    The Sirecust 420 Patient Dialog Monitor is supplied as a reusable medical device. It is intended for use in hospital or clinical environments where patient communication is critical, following standard protocols for reusable medical equipment.

  • What regulatory classification does the Sirecust 420 Patient Dialog Monitor hold?

    The Sirecust 420 Patient Dialog Monitor is classified as a Class II device under FDA regulation 870.2450. It received a 510(k) clearance (K851400) in 1985, with a decision of 'Substantially Equivalent' by the Cardiovascular Advisory Committee.

  • Does the Sirecust 420 Patient Dialog Monitor have specific sterility requirements?

    The regulatory data for the Sirecust 420 Patient Dialog Monitor does not specify any particular sterility requirements. As a reusable device, it follows standard medical device protocols for cleaning, disinfection, and maintenance.

  • Is the Sirecust 420 Patient Dialog Monitor MRI-safe or MRI-conditional?

    The Sirecust 420 Patient Dialog Monitor is not classified as MRI-safe or MRI-conditional. This means it should not be used in MRI environments, as its compatibility with magnetic resonance imaging has not been established.